Systemic Anti-Cancer Therapy Data Set

IntroductionThe Systemic Anti-Cancer Therapy Data Set collects clinical management information on PATIENTS undergoing Systemic Anti-Cancer Therapy in (or funded by) the NHS in England

Description

Introduction

The Systemic Anti-Cancer Therapy Data Set collects clinical management information on PATIENTS undergoing Systemic Anti-Cancer Therapy in (or funded by) the NHS in England.

In the clinical setting its primary use is in prescribing and administering Systemic Anti-Cancer Therapy. The standard also specifies secondary uses information about Systemic Anti-Cancer Therapy which is required to assist in achieving, supporting and monitoring the NHS Operating Framework, specialised commissioning and related policy.

Details of Standard

The Systemic Anti-Cancer Therapy Data Set relates to all cancer PATIENTS, both adult and paediatric, in both admitted PATIENT care and outpatient and community settings, who are receiving Systemic Anti-Cancer Therapy for all solid Tumour and haematological malignancies, including those treated in CLINICAL TRIALS.

The Systemic Anti-Cancer Therapy Data Set covers the period from the Start Date of the Systemic Anti-Cancer Therapy Drug Regimen to the Start Date of the last Systemic Anti-Cancer Therapy Drug Cycle.

Note: PATIENTS may end their treatment with an oral or other component taken at home. Although the dispensing of this will be recorded in the final Systemic Anti-Cancer Therapy Drug Cycle, it is not possible to confirm that the PATIENT has taken the medication.

Data Set Structure and Transmission

Systemic Anti-Cancer Therapy is given over a prolonged period of time, often months or years, comprising repeating and sequential elements. The PATIENT may attend two or more Health Care Providers during the course of treatment.

In order to track the PATIENT during treatment, the data set must be capable of linking all the elements of care in a consistent and ordered way. In order to achieve this, the Systemic Anti-Cancer Therapy Data Set has a branching structure which links the initial data fields, which will remain constant during the treatment, with detail of each Systemic Anti-Cancer Therapy Drug Regimen, Systemic Anti-Cancer Therapy Drug Cycle and Systemic Anti-Cancer Therapy Drug Administration. At the completion or cessation of a Systemic Anti-Cancer Therapy Drug Regimen, the outcome section must link back to all previous fields. It must be possible to reconstitute details of each PATIENT's sequential management from the serial downloads received.

All NHS Trusts and NHS Foundation Trusts providing Systemic Anti-Cancer Therapy Services are required to submit monthly data downloads to an agreed timetable, two months in arrears. These data must represent all treatment activity in the month period, including Systemic Anti-Cancer Therapy Drug Regimens started and completed or ceased in the REPORTING PERIOD.

The data repository is hosted by the National Disease Registration Service ( NDRS), which is part of NHS England. The data is held under the National Disease Registries Directions 2021, which was reissued on 2 February 2023.

This is supported by the National Disease Registration Service: Data Provision Notice.

Data downloads is by csv and will uniquely identify the Health Care Provider.

Further Guidance

Detailed technical guidance on the processes required, and any required updates, is available from the National Disease Registration Service in the Systemic Anti-Cancer Therapy (SACT) data set: Downloads supporting the programme.

Mandation

The Mandation column indicates the recommendation for the inclusion of data.

M = Mandatory: this data element is mandatory and the technical process (e.g. submission of the data set, production of output etc) cannot be completed without this data element being present
R = Required: NHS business processes cannot be delivered without this data element.

Data Set Constraints

For guidance on the Data Set constraints, see the Systemic Anti-Cancer Therapy Data Set Constraints.

Specification


LINKAGE - PATIENT IDENTITY DETAILS: LINKAGE IDENTIFIER CHOICE
Mandation	CHOICE 1 - NHS NUMBER To carry patient identity details for linkage. One occurrence of this group is required if selected as the choice.
M	NHS NUMBER
Or
Mandation	CHOICE 2 - LOCAL PATIENT IDENTIFIER To carry patient identity details for linkage. One occurrence of this group is required if selected as the choice.
M	LOCAL PATIENT IDENTIFIER (EXTENDED)


LINKAGE - PATIENT IDENTITY DETAILS One occurrence of this group is required.
Mandation	Data Elements
M	NHS NUMBER STATUS INDICATOR CODE
M	PERSON BIRTH DATE
M	ORGANISATION IDENTIFIER (CODE OF PROVIDER)


DEMOGRAPHICS AND CARE PROFESSIONAL DETAILS One occurrence of this group is permitted.
Mandation	Data Elements
M	PERSON FAMILY NAME
M	PERSON GIVEN NAME
R	PERSON STATED GENDER CODE
M	POSTCODE OF USUAL ADDRESS


DEMOGRAPHICS AND CARE PROFESSIONAL DETAILS: CARE PROFESSIONAL INITIATING TREATMENT One occurrence of this group is permitted per Demographics and Care Professional Details.
Mandation	Data Elements
M	PROFESSIONAL REGISTRATION ISSUER CODE (INITIATED SYSTEMIC ANTI-CANCER THERAPY)
M	PROFESSIONAL REGISTRATION ENTRY IDENTIFIER (INITIATED SYSTEMIC ANTI-CANCER THERAPY)


DEMOGRAPHICS AND CARE PROFESSIONAL DETAILS: CONTINUED One occurrence of this group is permitted.
Mandation	Data Elements
R	CARE PROFESSIONAL MAIN SPECIALTY CODE (START SYSTEMIC ANTI-CANCER THERAPY)


CLINICAL STATUS: DIAGNOSIS CHOICE
Mandation	CHOICE 1 - ICD To carry diagnosis identifier details for ICD. One occurrence of this group is required if selected as the choice.
M	PRIMARY DIAGNOSIS (ICD-10 AT START SYSTEMIC ANTI-CANCER THERAPY)

Mandation	CHOICE 2 - ICD-O To carry diagnosis identifier details for ICD-O. One occurrence of this group is required if selected as the choice.
M	MORPHOLOGY (ICD-O AT START SYSTEMIC ANTI-CANCER THERAPY)


CLINICAL STATUS One occurrence of this group is required.
Mandation	Data Elements
R	DIAGNOSIS (SNOMED CT)


REGIMEN One occurrence of this group is permitted.
Mandation	Data Elements
R	SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN TREATMENT CONTEXT
R	SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN TREATMENT INTENT


REGIMEN: LINE OF TREATMENT CHOICE
Mandation	CHOICE 1 - CURATIVE To carry Line of Treatment identifier details for Curative Treatment. One occurrence of this group is required if selected as the choice.
M	SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN LINE OF CURATIVE TREATMENT
Or
Mandation	CHOICE 2 - NON-CURATIVE To carry Line of Treatment identifier details for Non-Curative Treatment. One occurrence of this group is required if selected as the choice.
M	SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN LINE OF NON-CURATIVE TREATMENT


REGIMEN - CONTINUED One occurrence of this group is permitted.
Mandation	Data Elements
M	SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN ACRONYM
R	PERSON HEIGHT IN METRES (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)
R	PERSON WEIGHT (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)
R	PERFORMANCE STATUS (ADULT START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)
R	DECISION TO TREAT DATE (SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)
M	START DATE (SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)
R	CLINICAL TRIAL INDICATOR
R	SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN GIVEN AS PART OF CHEMORADIATION INDICATOR


REGIMEN: REGIMEN MODIFICATION One occurrence of this group is permitted per Regimen.
Mandation	Data Elements
M	SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION INDICATOR
R	SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION REASON Multiple occurrences of this item are permitted
R	SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN PATIENT CLINICAL FACTORS UPFRONT DOSE MODIFICATION REASON Multiple occurrences of this item are permitted
R	COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS TOXICITY GRADE (SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN UPFRONT DOSE MODIFICATION)


CYCLE Multiple occurrences of this group are permitted. One for each Systemic Anti-Cancer Therapy Cycle.
Mandation	Data Elements
M	SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE IDENTIFIER
M	START DATE (SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE)
R	PERSON WEIGHT (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE)
R	PERFORMANCE STATUS (ADULT START OF SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE)


CYCLE: CYCLE MODIFICATION One occurrence of this group is permitted per Cycle.
Mandation	Data Elements
M	SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION INDICATOR
R	SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION REASON Multiple occurrences of this item are permitted
R	SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DRUG OMISSION REASON Multiple occurrences of this item are permitted
R	COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS TOXICITY GRADE (SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION)


CYCLE: CYCLE DELAY One occurrence of this group is permitted per Cycle.
Mandation	Data Elements
M	SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DELAY INDICATOR
R	SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DELAY REASON Multiple occurrences of this item are permitted
R	SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DELAY REASON Multiple occurrences of this item are permitted
R	COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS TOXICITY GRADE (SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DELAY)


DRUG DETAILS Multiple occurrences of this group are permitted. One for each Systemic Anti-Cancer Therapy Drug.
Mandation	Data Elements
M	SYSTEMIC ANTI-CANCER THERAPY DRUG NAME
R	SYSTEMIC ANTI-CANCER THERAPY TOTAL DAILY DOSE
R	UNIT OF MEASUREMENT (SYSTEMIC ANTI-CANCER THERAPY)
M	OTHER UNIT OF MEASUREMENT DESCRIPTION (SYSTEMIC ANTI-CANCER THERAPY)
R	UNIT OF MEASUREMENT (DM+D)
R	SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION
R	ROUTE OF ADMINISTRATION (SNOMED CT)


DRUG DETAILS: ADMINISTRATION DATE CHOICE
Mandation	CHOICE 1 - ADMINISTRATION: TIMESTAMP To carry drug details for Timestamp. One occurrence of this group is required if selected as the choice.
M	CODED PROCEDURE TIMESTAMP (INFUSION ADMINISTRATION)
Or
Mandation	CHOICE 2 -ADMINISTRATION :DATE To carry drug details for date. One occurrence of this group is required if selected as the choice.
M	SYSTEMIC ANTI-CANCER THERAPY ORAL DRUG DISPENSED DATE


DRUG DETAILS: CONTINUED Multiple occurrences of this group are permitted. One for each Systemic Anti-Cancer Therapy Drug.
Mandation	Data Elements
R	SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE LENGTH IN DAYS
R	NUMBER OF SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLES ADMINISTERED
R	ORGANISATION IDENTIFIER (OF SYSTEMIC ANTI-CANCER THERAPY ADMINISTRATION)


DRUG DETAILS: DOSE MODIFICATION One occurrence of this group is permitted per Drug Details.
Mandation	Data Elements
M	SYSTEMIC ANTI-CANCER THERAPY DRUG DOSE MODIFICATION INDICATOR
R	SYSTEMIC ANTI-CANCER THERAPY DRUG DOSE MODIFICATION REASON Multiple occurrences of this item are permitted
R	SYSTEMIC ANTI-CANCER THERAPY DRUG PATIENT CLINICAL FACTORS DOSE MODIFICATION REASON Multiple occurrences of this item are permitted
R	COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS TOXICITY GRADE (SYSTEMIC ANTI-CANCER THERAPY DRUG DOSE MODIFICATION)


OUTCOME Multiple occurrences of this group are permitted.
Mandation	Data Elements
R	SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN COMPLETION OR END REASON Multiple occurrences of this item are permitted

Also Known As

This Data Set is also known by these names:

Context	Alias
Schema	SACT
Short name	Systemic Anti-Cancer Therapy